手紙:ファクターVIII

Same author

[The yet unexpected vitamin K deficiency].

Nederlands tijdschrift voor geneeskunde·1986

Same author

The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.

Thrombosis and haemostasis·1985

Same author

Carrier detection of haemophilia B by using an intragenic restriction-fragment length polymorphism.

Thrombosis and haemostasis·1985

Same author

The prophylactic treatment of hemophilia B Leyden with anabolic steroids.

Annals of internal medicine·1985

Same author

[Search for the carrier state of hemophilia B using restriction fragment length polymorphism].

Nederlands tijdschrift voor geneeskunde·1985

Same author

Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma.

Scandinavian journal of haematology·1985

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

手紙:ファクターVIII

関連する概念動画

[The yet unexpected vitamin K deficiency].

The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.

Carrier detection of haemophilia B by using an intragenic restriction-fragment length polymorphism.

The prophylactic treatment of hemophilia B Leyden with anabolic steroids.

[Search for the carrier state of hemophilia B using restriction fragment length polymorphism].

Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

手紙:ファクターVIII

関連する概念動画

関連記事

[The yet unexpected vitamin K deficiency].

The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.

Carrier detection of haemophilia B by using an intragenic restriction-fragment length polymorphism.

The prophylactic treatment of hemophilia B Leyden with anabolic steroids.

[Search for the carrier state of hemophilia B using restriction fragment length polymorphism].

Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.